89Zr-labeled Pembrolizumab in Patients With Non-small-cell Lung Cancer

NCT03065764 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: 89Zr-Pembrolizumab

Sponsor

Amsterdam UMC, location VUmc

Collaborators

[object Object]